Welcome to BRMEC10

Day 1 of the Colloquium.
BRMEC10 is the tenth Biomedical Research into ME Colloquium organised by the charity.

All delegates to BRMEC10 will have received instructions on joining the meeting via email beforehand including information about the topics under discussion.
Each day will begin promptly at the published times.

Status Review

The Colloquium begins with an overview of the current status of research and has presentations from different areas.
Speakers are to be announced.

Epidemiology of ME (and Covid)

This section will look at the epidemiological evidence related to ME as well as reviewing the recent accruement of knowledge from COVID-19 research.

Hypotheses discussed include historical evidence for infectious agents including environmental and endogenous viruses and bacteria being associated with the onset and “outbreaks” of ME/CFS
in relation to COVID-19, genetically susceptible individuals are at increased risk of developing ME/CFS after SARS-CoV-2 infection resulting in an increase of symptoms fulfilling the diagnostic criteria of ME/CFS amongst infected individuals.

Speakers will represent these hypotheses which will then be discussed by delegates.

Professor Markku Partinen

Professor of Medicine, University of Helsinki, Finland

Professor Partinen is a neurologist and an internationally well-known opinion leader and expert in sleep research and sleep medicine.

He is currently working as Research Director of the Helsinki Sleep Clinic, Vitalmed Research Centre.
He works also at Haartman Institute, University of Helsinki, and at Akademiska Sjukhuset, University of Uppsala.

His expertise covers sleeping, nutrition (what to eat), and other aspects of modern life and well-being.
His current research projects include narcolepsy, Parkinson's disease, insomnia, traffic accidents and daytime sleepiness.

He has published more than 250 articles in peer-reviewed international journals, several books and chapters.

He was recently (Now 2015) elected as the new President of the Finnish Parkinson Association. Professor Partinen is also a member of the European ME Research Group (EMERG) and European ME Clinicians Council (EMECC).

Professor Friðbjörn Sigurðsson

Dr Friðbjörn Sigurdsson is Program Director Internal Medicine, Landspitali University Hospital in Rejkjavik, Iceland.Friðbjörn


  • Program Director Internal Medicine, Landspitali University Hospital (since October 1 2013)
  • Attending Medical Oncology, Landspitali University Hospital (since April 1 2001)
  • Attending Hematology, Landspitali University Hospital (part time since May 2009)
  • Medical Oncology and Hematology, Akureyri Hospital (part time since June 2010)


  • Chief Internal Medicine, Landspitali University Hospital
  • Chief Medical Council Landspitali University Hospital, Iceland
  • Attending, Oncology, Landspitali Hospital, Reykjavik, Iceland
  • Attending, Internal Medicine, Reykjavik City Hospital, Iceland
  • Læknasetrið – private practice, Reykjavik, Iceland
  • Chief Internal Medicine, Neskaupstadur Hospital, Iceland
  • Chief Internal Medicine Vestman Islands Hospital, Iceland
  • Stykkishólmur, heilsugæsla og sjúkrahús.

Professor Simon Carding

Professor Simon Carding Research Leader, Quadram Institute Bioscience, Norwich Research Park, UK

Upon completing postgraduate work at the Medical Research Council’s Clinical Research Centre in Harrow, Professor Carding “emigrated” to the USA to take up a postdoctoral position at New York University School of Medicine, and then at Yale University as a Howard Hughes Fellow in the Immunobiology Group at Yale University with Profs Kim Bottomly and Charlie Janeway Jr. While at Yale an interest in gamma-delta (γδ) T cells was acquired working closely with Adrian Hayday on molecular genetics and then with Prof. Peter Doherty to establish their role in (viral) infectious disease.

He left Yale after five years to take up a faculty position at the University of Pennsylvania in Philadelphia where he developed a research interest in mucosal and GI-tract immunology, performing studies in germfree mice with Prof John Cebra that helped establish the role of gut microbes in the aetiology of inflammatory bowel disease (IBD).

After 15 years in the USA, he returned to the UK to take up the Chair in Molecular Immunology at the University of Leeds where he established a new research programme on commensal gut bacteria and Bacteroides genetics leading to the development of a Bacteroides drug delivery platform that is being used for developing new interventions for IBD and for mucosal vaccination.

In 2008 he was recruited by UEA and IFR to develop a gut research programme, taking up the Chair of Mucosal Immunology at UEA-MED and the position of head of the Gut Biology Research Programme at IFR, which later became part of the Gut Health and Food Safety (GHFS) Programme.

GHFS research covers a broad area of gut biology including epithelial cell physiology, mucus and glycobiology, mucosal immunology, commensal microbiology, foodborne bacterial pathogens, and mathematical modelling and bioinformatics. The success of this programme has led to the establishment of the Gut Microbes and Health research programme that is integral to the research agenda of The Quadram Institute.

Professor Leonard Jason, DePaul University, Chicago,USA

Professor Leonard Jason has been among the most prolific of all ME/CFS researchers. For more than a decade, Dr Jason and his team at DePaul University’s Centre for Community Research in Chicago have worked to define the scope and impact of ME/CFS worldwide. Dr Jason has been a key driver of ME/CFS research since 1991, and is uniquely positioned to support collaboration between ME/CFS researchers, patients, and government decision makers. His studies have shown that the direct and indirect costs of ME/CFS amount to $20 billion in the U.S. each year, and more than 1 million people suffer from ME/CFS as opposed to the estimated 20,000 people originally reported by the CDC (Centers for Disease Control and Prevention).

Researchgate Professor Leonard Jason

Dr Hilma Hólm, Head of Cardiovascular, DeCode Genetics, Reykjavik, Iceland

Hilma received her medical degree from the University of Iceland in 2000.
She completed her internal medicine training at Baylor College of Medicine in Houston, and her clinical cardiology training at Emory University in Atlanta.
She then pursued research training in cardiovascular genetics at deCODE in Iceland.
Hilma has been on faculty at deCODE since 2008 and currently leads the company´s cardiovascular effort.
She is actively involved in a wide range of cardiovascular research, including lipids and atherosclerosis, conduction and arrhythmias, congenital heart disesae and heart failure.

Hilma also completed training in clinical echocardiology at Mayo Clinic in Rochester, Minnesota, in 2014, and is actively involved with patient care at Landspitalinn, the National University Hospital.

Source: https://www.decode.com/management/

ANS and Autoimmunity

Hypothesis: Autonomic dysfunction and autoantibodies

Dr Jesper Mehlsen

Research Director, Coordinating Research Centre, Bispebjerg and Frederiksberg Hospital, Denmark
Co-chair European ME Research Group

Autonomic nervous system; Heart rate and blood pressure control; Cardiovascular physiology and pathophysiology;
HPV vaccines and -complications
Main research areas Methods for the study of autonomic cardiovascular control; Mathematical modelling of cardiovascular control; Autoimmune response to vaccination; Mathematical modeling of the neuroinflammatory reflex
Current research Mathematical analysis of hemodynamic adaptations to the upright posture.
Mathematical analysis of hemodynamic response to Valsalva manoeuvre
Dynamic T-wave alterations and the autonomic nervous system
Mathematical analysis of cytokine response to LPS in humans
Autoimmunity in patients with possible side effects to HPV vaccination

Mitochondrial Dysfunction

Hypothesis: Mitochondrial metabolic dysfunction in ME

During this session, we will discuss potential causes of this mitochondrial metabolic dysfunction in ME, how it may relate to PEM and fatigue, and if attempts to revert it by pharmaceutical and diet manipulation will reverse or worsen ME symptom burden.

Associate Professor Rikke Katrine Jentoft Olsen
Research Unit for Molecular Medicine, Department of Clinical Medicine, Aarhus University, Denmark

Our research group has a longstanding interest in inborn errors of mitochondrial metabolism with special focus on fatty acid oxidation disorders. We integrate genetic diagnostics of affected families with research into cell pathological mechanisms and novel treatment modalities in the form of mitochondrial vitamins/co-factors and anaplerotic compounds for the tricarboxylic acid cycle. In recent years, we have initiated research programs to understand the role that mitochondria may play in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Besides science, Rikke KJ Olsen is an active member of the Neonatal Screening Program for inborn errors of metabolism in Denmark and board member of international scientific organisations within fatty acid oxidation disorders and ME/CFS.

Professor Karl Johan Tronstad

Professor Tronstad completed his graduate studies in biochemistry at the University of Bergen (UiB) in 2002. As postdoc at the Haukeland University Hospital, he studied bioactive compounds with the potential to modulate mitochondrial functions in cancer cells. In 2005 he was recruited to the Department of Biomedicine, UiB, where he started his research group to investigate metabolism and mitochondrial physiology. His laboratory seeks to better our understanding of how defective mitochondrial homeostasis may disturb cell physiology, and how this may be involved in mechanisms of cancer and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Karl was involved with the recent paper to come from Bergen - Journal of Clinical Investigation Insight.

The Tronstad Lab investigates cell metabolism and mitochondrial biology.

Metabolism, Cell biology, Mitochondria, Biochemistry

Dr. Bhupesh K Prusty, Principal Investigator, Institute for Virology and Immunobiology, Würzburg, Germany

Dr. Bhupesh Prusty is Group Leader in the Department of Microbiology at the University of Würzburg in Germany

Dr. Bhupesh Prusty finished his Doctoral studies in New Delhi, India and afterwards started his professional scientific life in Germany in 2006 with Prof. Harald zur Hausen.
Afterwards he started his own research group in 2014 and since then he has been involved with herpesvirus research. As an independent researcher, he has made significant discoveries to understand molecular mechanisms of HHV-6/HHV-7 latency and reactivation. His major achievements include identifying molecular mechanism of HHV-6 reactivation by telomeric-circle formation, the finding of HHV-6A infection in neuronal Purkinje cells of bipolar patients and the characterization of mitochondrial dysfunction in ME/CFS.

His current research interest involves studying molecular biology of HHV-6/HHV-7 encoded small non-coding RNAs and their potential role in human diseases.

Professor Tom Wileman, Quadram Institute, Norwich,UK

2007- present Director, Biomedical Research Centre, University of East Anglia
1997-2005 Head of Department of Immunology and Pathology, Institute for Animal Health, Pirbright Laboratory, Woking, Surrey.
1994-1997 Head, Virus Cell Biology Group, Institute for Animal Health, Pirbright Laboratory, Woking, Surrey.
1991-1996 Assistant Professor, Department of Medicine, Harvard Medical School, Boston USA.
1991 - 1994 Assistant Professor, Division of Immunology, Beth Israel Hospital, Harvard Medical School, Boston, MA.
1988-1992 Claudia Adam's Barr Investigator in Cancer Research, Fellow of the Medical Foundation of the Charles King Trust and Basil O'Connor Scholar Award of the March of Dimes Research Foundation, Dept Molecular Immunology, Dana Farber Cancer Institute, Harvard Medical School
1982-1988 BBSRC NATO Fellow and Fellow of the Parker Francis Pulmonary Research Foundation. Department of Cell Biology, Washington University Medical School, St Louis.

The Wileman group at the Quadram Institute studies how viruses activate autophagy during cell entry and replication.

Dr Amolak Bansal

Consultant Immunologist, Spire Hospitals, Surrey, UK

Previously, Consultant in Immunology/Allergy and CFS/ME, Department of Immunology and Allergy, St Helier Hospital, Carshalton, Surrey.

Professor Aletta D. Kraneveld

Chair Interdisciplinary Translational Pharmacology| Division of Pharmacology | Department of Pharmaceutical Sciences | Utrecht Institute for Pharmaceutical Sciences, Utrecht University , Netherlands

Aletta Kraneveld, full professor Interdisciplinary Translational Pharmacology at the Faculty of Science and the faculty of Veterinary Medicine of the Utrecht University has published over 100 papers (H-index: 35).
Besides science, she is an active member of several (advisory) boards of national and international scientific organisations.
The Kraneveld group is focused on research into the role of the gut-immune-brain-axis in neurodevelopmental and neurodegenerative disorders including the interaction of microbiota and their fermentation products with the immune and nervous system.

Professor Elisa Oltra, Head of the Genetic Expression and Immunity group of the Faculty of Medicine at the Catholic University of Valencia, Spain

Elisa Oltra currently works at the Catholic University of Valencia, Valencia, Spain. Elisa does research in Cancer Research, Cell Biology and Genetics.

Professor Branislav Milovanović, University Clinical Center Bezanijska Kosa, Department of Cardiology,Neurocardiological laboratory, Belgrade, Serbia

Prof. Dr. Branislav Milovanović is a specialist in internal medicine - a cardiologist from Belgrade. He is employed at the Bežanijska Kosa Clinical Hospital, in the position of the head of the Neurocardiology Laboratory, of which he is also the founder. He is a professor of cardiology at the Department of Internal Medicine at the Faculty of Medicine in Belgrade. He studied at some of the world's best cardiology centers, in Germany, Great Britain, Italy and America.

In Serbia, he is one of the first to deal with neurocardiology , a new scientific branch that studies the relationship between the nervous and cardiovascular systems. He introduced new diagnostic methods: nonlinear cardiology, short-term and long-term analysis of RR variability with spectral analysis, cardiovascular reflex tests with spectral analysis, and real time continuous measurement of blood pressure.

Prof. Dr. Branislav Milovanović founded the Section of the Serbian Medical Association for the Autonomic Nervous System, as well as the Association for Neurocardiology of Serbia, which is the fourth such association in the world.

He is the author of a large number of scientific papers published in domestic and foreign journals of importance, as well as one monograph. He is the organizer of numerous professional gatherings, through which he brought some of the world's biggest names in cardiology to Serbia. He often visits as a lecturer by invitation at foreign congresses. During his career, he received numerous awards, including the American Hypertension Association Award.


  • • Head of Neurocardiological laboratory,CHC B.Kosa
  • • Professor of Internal medicine and Cardiology,Medical faculty,University in Belgrade,Serbia
  • • Professor of Internal medicine,Alma Mater Europea,University in Salzburg,Austria,European Center Maribor,Slovenia
  • • Director of Internal Clinic University Clinical Center Bezanijska Kosa


  • • Postdoctoral training
  • • KreisKrankenhaus Ebersberg, Muenchen, Cardiology and Internal department
  • • Laboratory for nonlinear dinamic, Klinikum recht der Isar,Department of Cardiology, University of Muenchen, September 1996 and 1997
  • • Neurovascular Unit,St Mary`s Hospital,Imperial College,
  • • Institute for Neurology,UCL,London ( after getting of Wellcome Trust Grant);25.1.1999.-25.2.1999.
  • • RUSH University of Chicago,Department of Cardiology ,20.2.2000-20.3.2000.
  • • Department of Cardiology, Instituto Auxologico Italiano, University of Milano, Ospedale San Luca, September 2001
  • • Medical Licensure
  • • 1987.Doctor in medicine,(MD).University of Belgrade
  • • Residency
  • • From 19.4.1990 to 20.5.1994.Specialists examination passed with an excellent grade at the school of medicine in Belgrade
  • • M.Sci.
  • • 1993:University of Belgrade
  • • Doctoral degrees
  • • 1994: Doctor of medical science,(PhD)
  • • Syncope
  • • All aspects of clinical investigation of autonomic nervous system in different diseases Noninvasive, electrocardiology, Chaos theory, Personalized medicine
  • • Nano medicine
  • • Placebo effect
  • • Neurocardiology

Professor Kristian Sommerfelt, Paediatric Neurologist at Haukeland University hospital in Bergen, Norway

Professor Kristian Sommerfelt is a paediatric neurologist at Haukeland University hospital in Bergen, NorwayKristian Sommerfelt

Professor Sommerfelt wrote the national guidelines (2019) for diagnosis, treatment and follow-up of ME/CFS children/ young people for the website NEL (Norsk Elektronisk Legehåndbok) - which is a web-based methods used the most by general practitioner doctors and also used extensively in hospitals. Over the last eight years he has given lectures and presentations at courses and conferences for health professionals and others in addition to teaching medical students.

Professor Maureen Hanson, Cornell University, USA

Maureen R. Hanson is Liberty Hyde Bailey Professor in the Department of Molecular Biology & Genetics. She received a B.S. degree at Duke University and a Ph.D. in Cell and Developmental Biology from Harvard University. After completing an NIH postdoctoral fellowship at Harvard, she joined the faculty of the Biology Department at University of Virginia. She moved to Cornell as Associate Professor and was promoted to Professor in 1991. She is presently a member of the graduate Fields of Genetics and Development, Plant Biology, and Biochemistry, Molecular, and Cell Biology. She has previously served as Associate Director of the Cornell Biotechnology Program and Director of the Cornell Plant Science Center. She is currently Director for the Center for Enervating Neuroimmune Disease.

Dr Linn Skjevling

Doctor and research fellow
Research and Education Unit
Medical department
UNN Harstad


Day 1 summary

Welcome to BRMEC10

Day 2 of the Colloquium.


To be confirmed

To be confirmed


Hypothesis -Immune and Immune genetic factors drive the development and progression of ME/CFS


Hypothesis: Host microbe interactions that affect the gut brain axis can predispose to ME/CFS


Hypothesis: Therapeutic strategies should target the triggering and subsequent signalling events that cause the hallmark clinical symptoms of ME.


Day 2 summary

Research tools for ME/CFS-related data and biospecimens

RTI International

Two new research tools developed by RTI International, the Data Management and Coordinating Center for the NIH-funded ME/CFS Collaborative Research Centers (CRCs) Network, are now available to help advance ME/CFS research by allowing researchers to access and share data and biospecimens.
An online data sharing platform that allows researchers to discover, share, and access data from multi-omic studies.
The platform was initially developed to support the ME/CFS Network CRCs that employ a variety of research methods (e.g., microbiome screens, RNA sequencing, mitochondrial assays, metabolomic assays) to identify potential biomarkers and study the underlying cause(s) of ME/CFS. mapMECFS allows researchers to search the contents of data sets across multiple studies, quickly compare results for specific molecules or markers of interest, and download relevant data to be used for exploration or validation studies. Additionally, mapMECFS encourages and facilitates sharing of new data by capturing key study metadata to make results easier to find.

An online, interactive search tool that allows researchers to query and request available biospecimens (e.g., DNA, RNA, urine, plasma, and peripheral blood mononuclear cells) based on specific demographic and clinical characteristics. The initial cohort, the Chronic Fatigue Initiative, was a research study supported by the Hutchins Family Foundation. Biospecimens and associated data were collected from 201 individuals with ME/CFS and 200 matched controls. The biospecimens are housed at the NINDS’ biomarker repository at Indiana University, and the data are hosted by RTI International. Investigators may also request access to just the clinical data for analysis. Additional cohorts’ biospecimens and datasets will be available in the future.

Open Discussion

this section is open to all delegates to discuss the preceding presentations

To be announced

To be announced

To be confirmed

To be confirmed

Dr Aimée Parker, Research Associate, Quadram Institute Bioscience, Norwich, UK

Dr Stefano Romano, Quadram Institute Bioscience, Norwich, UK

Assistant Professor Bradlee Heckmann, University of South Florida, Health, Neuroscience Institute, Byrd Alzheimer's Center, USA

Bradlee L. Heckmann is an American biologist and neuroimmunologist who is currently an investigator at the Byrd Alzheimer's Center and USF Health Neuroscience Institute and assistant professor in molecular medicine at the USF Health Morsani College of Medicine. Prior to his faculty appointment, Heckmann held the John H. Sununu Endowed Fellowship[1] in immunology at St. Jude Children's Research Hospital. Heckmann's research is focused on understanding the regulation of inflammatory processes in the central nervous system, with particular emphasis on neurodegenerative diseases including Alzheimer's Disease[2] and the role of the autophagy machinery in this setting. Source: Wikipedia

Dr. Gerd Wallukat, UMax-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany

Dr. Wallukat led the research team that discovered the role of autoantibodies in dilated cardiomyopathy. He has been instrumental in investigating the role and function of autoantibodies in heart disease and other conditions at the Max-Delbrück-Center of Molecular Medicine in Berlin.

Dr. Wallukat also co-founded Affina Immuntechnik GmbH to to develop an adsorber for the new therapeutic option of immunoadsorption.

He is currently researching new ways to neutralize pathogenic autoantibodies without immunoadsorption.

Dr. Wallukat studied biology in Berlin and Leipzig and began his scientific work at the Institute of Cardiovascular Research of the Academy of Sciences with Prof. A. Wollenberger. After the unification of Germany he worked as head of a working group at the Max Delbrück Center of Molecular Medicine examining the immunology of cardiovascular diseases.


Dr Avindra Nath, Clinical Director / Senior Investigator, Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke (NINDS), USA

Dr. Nath received his MD degree from Christian Medical College in India in 1981 and completed a residency in Neurology from University of Texas Health Science Center in Houston, followed by a fellowship in Multiple Sclerosis and Neurovirology at the same institution and then a fellowship in Neuro-AIDS at NINDS.

He held faculty positions at the University of Manitoba (1990-97) and the University of Kentucky (1997-02).

In 2002, he joined Johns Hopkins University as Professor of Neurology and Director of the Division of Neuroimmunology and Neurological Infections.

He joined NIH in 2011 as the Clinical Director of NINDS, the Director of the Translational Neuroscience Center and Chief of the Section of Infections of the Nervous System.

His research focuses on understanding the pathophysiology of retroviral infections of the nervous system and the development of new diagnostic and therapeutic approaches for these diseases.


Dr. Brian Walitt, Medical Officer, Symptom Management Branch, Division of Intramural Research, National Institute of Nursing Research, USA

Dr. Brian Walitt’s research seeks to better define the nature of chronic symptoms. His expertise in epidemiology allows for the characterization of symptom disorders and their impact on society.
As NINR’s Medical Officer, Dr. Walitt collaborates with the scientists in the Division of Intramural Research to understand the biological mechanisms for a wide array of symptoms, including their effects on patients and how patients respond to interventions.
Increasing scientific understanding of the nature of symptoms will provide these individuals and their families with more clarity about their symptoms and potentially translate into meaningful interventions.

Serves as the Acting Clinical Director of the National Center for Complementary and Integrative Health
Serves as the Medical Officer for the National Institute of Dental and Craniofacial Research
Completed his Internal Medicine residency training at George Washington University Hospital and his Rheumatology fellowship training at the MedStar Health Washington Hospital Center
Served as an Adjunct Associate Professor at Georgetown University


Emeritus Professor Warren Tate, Department of Biochemistry, University of Otago, New Zealand

Emeritus Professor Warren Tate from University of Otago in New Zealand - is an internationally respected biochemist, winner of the Royal Society of New Zealand's top science honour - the 2010 Rutherford Medal, and was also named a Companion of the New Zealand Order of Merit.
His honour citation noted that Professor Tate was a molecular biologist, whose research had "revolutionised understanding" of how proteins were synthesised in living cells. His research had shown how proteins contributed to memory formation and neurological disease, and had important implications for HIV, Alzheimer's and chronic fatigue syndrome.

Emeritus Professor Warren Tate FRSNZ CNZM

• Professor Warren Tate has been an academic and researcher at the University of Otago in Dunedin, New Zealand spanning 54 years.

• He is a Fellow of the Royal Society of New Zealand, and internationally, a Fellow of the Alexander von Humboldt Foundation of Germany, and was an International Research Scholar of the Howard Hughes Medical Institute of the United States.

• He is currently an Emeritus Professor working full time but having formally retired in 2020

• Professor Tate’s research currently has a strong interest in unexplained human diseases.

• Initially he was a discovery molecular biologist with a fundamental interest in how proteins are made in our cells, and how protein synthesis and the genetic code arose 3-4 billion years ago. He co-discovered a new rare mechanism of gene regulation, translational frameshifting.

• Professor Tate also works on mammalian memory and Alzheimer’s disease and the development of a potential therapeutic agent based on a natural neuroprotective brain protein, secreted amyloid precursor protein alpha.

• Most recently in 2012 he established a research programme on Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) focussing on preclinical studies with New Zealand patients.

• Professor Tate approaches research on ME/CFS through the dual lens of an affected family of 30 years and a biomedical researcher. He has found molecular signatures for the illness supporting its biological basis and is now studying whether Post Covid-syndrome (Long COVID) long haulers who have ongoing illness from SARS-CoV-2 infection have the same molecular signatures found in ME/CFS.

Professor Tate is a Fellow of the Royal Society of New Zealand and of the New Zealand Institute of Chemistry.
He has been a Fellow of the Alexander von Humboldt Foundation of Germany, and an International Research Scholar of the Howard Hughes Medical Institute of the United States.

Read more:https://www.otago.ac.nz/biochemistry/people/profile/index.html?id=37

Professor Dr. Tanja Lange, Department of Rheumatology, University of Lübeck, Lübeck, Germany

After Medical School Prof. Lange combined her clinical training in Internal Medicine with basic research on sleep-immune interactions in healthy individuals in the frame of DFG-funded interdisciplinary consortia on sleep and (immunological) memory formation. After her board certification and habilitation in Internal Medicine, she started her clinical training in Rheumatology, received a professorship for psychoneuroimmunology and currently delineates brain-immune interactions in patients with systemic autoimmune diseases.
Source: https://northship.org/about-us/tanja-lange/

Read more:https://www.grk1727.uni-luebeck.de/people/associated-scientists/tanja-lange.html

Time Conversions from Central European Time(CET)

  • UK Time - 1 hour
  • Finnish Time + 1 hour
  • USA East Coast Eastern Time - 5 hours
  • USA West Coast Pacific Time - 8 hours
  • Australian Eastern Standard Time + 9 hours
  • New Zealand Time + 11 hours
Find the current time in your country